Paramedian forehead flap in the treatment of nasal, non-melanoma skin cancer: a cross-sectional study.

Autor:	Ribeiro RDA; - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Serviço de Cirurgia Plástica - São Paulo - SP - Brasil., Pagotto VPF; - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Serviço de Cirurgia Plástica - São Paulo - SP - Brasil., Takahashi GG; - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Serviço de Cirurgia Plástica - São Paulo - SP - Brasil., Tutihashi RMC; - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Serviço de Cirurgia Plástica - São Paulo - SP - Brasil.; - Instituto do Câncer do Estado de São Paulo, Serviço de Cirurgia Plástica - São Paulo - SP - Brasil., Camargo CP; - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Serviço de Cirurgia Plástica - São Paulo - SP - Brasil., Busnardo FF; - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Serviço de Cirurgia Plástica - São Paulo - SP - Brasil.; - Instituto do Câncer do Estado de São Paulo, Serviço de Cirurgia Plástica - São Paulo - SP - Brasil., Gemperli R; - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Serviço de Cirurgia Plástica - São Paulo - SP - Brasil.
Jazyk:	English; Portuguese
Zdroj:	Revista do Colegio Brasileiro de Cirurgioes [Rev Col Bras Cir] 2022 Sep 02; Vol. 49, pp. e20223034. Date of Electronic Publication: 2022 Sep 02 (Print Publication: 2022).
DOI:	10.1590/0100-6991e-20223034-en
Abstrakt:	Introduction: nose is the central point of the face and vulnerable to the occurence of non-melanoma skin cancer (NMSC), impacting on appearance. The paramedian forehead flap (PMFF) is considered the best option to treat extensive nasal defects. The objective of this study is to present the experience on PMFF for nasal reconstruction in the treatment of NMSC of a cancer referral center. Methods: retrospective study was carried out through data from medical records of patients who underwent nasal reconstruction with PMFF due to NMSC at the Cancer Institute of the State of São Paulo (ICESP). Results: 111 patients were identified, mostly ederly, with comorbidities and on initial tumors (T1 and T2). Basal cell carcinoma (BCC) was the predominant histological type. Dorsum and tip were the most affected subunitis. In addition to skin coverage, reconstruction of the lining and structural framework was also performed in half of the cases. Second intention healing was the technique of choice in closing the donor area. Pedicle division ocurred predominantly in the second operation and the median time to complete reconstruction was 6 months. There were low complication rates. Conclusions: the PMFF is safe and effective to treat nose NMSC, even in cases of high complexity. Since the treatment time can be prolonged and impact on quality of life, it is essential to emphasize and discuss this aspect with the patients before surgery.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu